How effective is Armodafinil for Somnolence (Drowsiness)? (a real world drug study)

Summary:

Overall ratings: 3.5/5
Long term ratings: 3.6/5

This is a phase IV clinical study of how effective Armodafinil (armodafinil) is for Somnolence and for what kind of people. The study is created by eHealthMe from 15 Armodafinil users and is updated continuously.

What is Armodafinil?

Armodafinil has active ingredients of armodafinil. It is often used in narcolepsy. eHealthMe is studying from 4,136 Armodafinil users. Check the latest studies of Armodafinil.

What is Somnolence?

Somnolence (a state of near-sleep, a strong desire for sleep) is found to be associated with 4,040 drugs and 4,840 conditions by eHealthMe. Check the latest studies of Somnolence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.


On Aug, 05, 2026

15 people are studied for taking Armodafinil in Somnolence

Overall effectiveness (number of people):

Does Armodafinil work for your Somnolence (overall)?

Long term (1+ years) effectiveness (number of people):

Does Armodafinil work for your Somnolence (long term)?

Armodafinil effectiveness for Somnolence (number of people):

Overall:
  • not at all: 0
  • somewhat: 4
  • moderate: 2
  • high: 7
  • very high: 2
Long Term:
  • not at all: 0
  • somewhat: 2
  • moderate: 1
  • high: 5
  • very high: 1

Gender of people who take Armodafinil for Somnolence *:

  • female: 40 %
  • male: 60 %

Age of people who take Armodafinil for Somnolence *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 20.0 %
  • 30-39: 13.33 %
  • 40-49: 26.67 %
  • 50-59: 26.67 %
  • 60+: 13.33 %

Who find Armodafinil more effective for Somnolence?

Gender of people who take Armodafinil for Somnolence *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who take Armodafinil for Somnolence *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 22.22 %
  • 30-39: 22.22 %
  • 40-49: 33.33 %
  • 50-59: 22.22 %
  • 60+: 0.0 %

* Approximation only. Some reports may have incomplete information.

Do you take Armodafinil?

- You can start a phase IV clinical trial to monitor Armodafinil safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on armodafinil (the active ingredients of Armodafinil) and Armodafinil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: